Viewing Study NCT00855894


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-01-23 @ 4:29 PM
Study NCT ID: NCT00855894
Status: COMPLETED
Last Update Posted: 2013-05-21
First Post: 2009-03-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer
Sponsor: Genentech, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tarceva View
None NSCLC View